Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin
article
OA: closed
CC0
⤵ 34 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Romidepsin treatment inhibited transcription, expression, and secretion of vascular epithelial growth factor (VEGF) in human epithelial endometriotic cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (37)
- Aberrant Expression of Leptin in Human Endometriotic Stromal Cells Is Induced by Elevated Levels of Hypoxia Inducible Factor-1α via openalex
- Angiogenic Factors in Endometriosis via openalex
- Anti-angiogenic treatment of endometriosis: biochemical aspects. via openalex
- Endometriosis via openalex
- Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells via openalex
- Identification of an Invasive, N-Cadherin-Expressing Epithelial Cell Type in Endometriosis Using a New Cell Culture Model via openalex
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis via openalex
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Role of endocrine status and cell type in adhesion of human endometrial cells to the peritoneum in nude mice via openalex
- The Pains of Endometriosis via openalex
- The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions via openalex
- Tissue integrity is essential for ectopic implantation of human endometrium in the chicken chorioallantoic membrane via openalex
- W2074077730 via openalex
- W2095228162 via openalex
- W2099803844 via openalex
- W2106357158 via openalex
- W2140246703 via openalex
- W2142233318 via openalex
- W2164385268 via openalex
- W4211081176 via openalex
- W6607524343 via openalex
- W6655318352 via openalex
- W186651553 via openalex
- W6665028483 via openalex
- W1580865462 via openalex
- W1966257589 via openalex
- W1977922402 via openalex
- W1981591956 via openalex
- W1983763042 via openalex
- W1985959551 via openalex
- W2001163191 via openalex
- W2004233759 via openalex
- W2016707829 via openalex
- W2032738969 via openalex
- W2039203273 via openalex
- W2058582218 via openalex
Cited by (34)
- A cRGD-modified liposome for targeted delivery of artesunate to inhibit angiogenesis in endometriosis 2025
- Recent Advances in Drug Treatment for Endometriosis in Adolescents 2025
- The long road of drug development for endometriosis - Pains, gains, and hopes 2024
- Luoshi Neiyi Prescription inhibits estradiol synthesis and inflammation in endometriosis through the HIF1A/EZH2/SF-1 pathway 2024
- Corroborating evidence for aberrant expression of histone deacetylase 8 in endometriosis 2023
- Epigenetic Dysregulation in Endometriosis: Implications for Pathophysiology and Therapeutics 2023
- The Impact of Histone Modifications in Endometriosis Highlights New Therapeutic Opportunities 2023
- Aberrant expression of histone deacetylase 8 in endometriosis and its potential as a therapeutic target 2023
- Endometriosis Research: From Bench to Bedside 2022
- The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions 2021
- Hypoxia and immune factors 2021
- Hyperbaric Oxygen (HBO) Reduce Expression of Hypoxia Inducible Factor-1 Alpha (HIF-1 alpha) and Endometriotic Tissue Size in Mice Model of Endometriosis 2020
- The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights 2019
- From pathogenesis to clinical practice: Emerging medical treatments for endometriosis 2018
- New developments in the medical treatment of endometriosis 2017
- Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis 2016
- Medikamentozno zdravljenje endometrioze: pregled stanja in nove možnosti zdravljenja 2016
- Hypoxia-inducible factor-1alpha: A promising therapeutic target in endometriosis 2016
- Pharmacological treatment of endometriosis: review of current and new options for treatment 2016
- Aberrant histone modification in endometriosis 2014
- Potential New Drugs for Endometriosis: Experimental Evidence 2014
- Transforming Growth Factor-β Induced Warburg-Like Metabolic Reprogramming May Underpin the Development of Peritoneal Endometriosis 2014
- Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells 2013
- Western Herbal Medicine, Epigenetics, and Endometriosis 2013
- Angiogenesis and Endometriosis 2013
- The Epigenetics of Endometriosis 2012
- Anti-angiogenic treatment strategies for the therapy of endometriosis 2012
- New trends for the medical treatment of endometriosis 2012
- Female Infertility and Free Radicals: Potential Role in Endometriosis and Adhesions 2012
- Medikamentöse Therapie der Endometriose 2012
- Endometriose, definiert als das Vorhandensein und Proliferieren von endometriumartigem Gewebe ausser- halb des Cavum uteri, ist eine häufige Ursache für chronische Unterbauchschmerzen, Dysmenorrhö und Sterilität. Insbesondere die medikamentöse Therapie ist angesichts der immer noch ungeklärten Patho- physiologie häufig eher symptom- als kausalorientiert. 2012
- Ein grundlegendes Verständnis der Pathogenese der Endometriose ist eine zwingende Voraussetzung zur Etablierung neuer und wirksamer Therapieoptionen. Dabei erscheint die Endometriose als heterogene Gruppe von Krankheitsformen, die sich unterschiedlich manifestieren. Dies erklärt, weshalb die genaue Pathogenese der Endometriose bis heute ein nicht abschliessend erforschtes Gebiet bleibt. 2012
- Histone deacetylase inhibitors as therapeutics for endometriosis 2012
- Endometriosis and Angiogenic Factors 2012
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:16:48.482574+00:00
License: CC0
· commercial use OK